Metabolic syndrome, plasma lipid, lipoprotein and glucose levels, and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC).

Translated title of the contribution: Metabolic syndrome, plasma lipid, lipoprotein and glucose levels, and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC).

A. Cust, R. Kaaks, C.M. Friedenreich, F. Bonnet, M. Laville, A. Tjonneland, A. Olsen, K. Overvad, M.U. Jakobsen, V. Chajes, F. Clavel-Chapelon, M.C. Boutron-Ruault, J. Linseisen, A. Lukanova, H. Boeing, T. Pischon, A. Trichopoulou, B. Christina, D. Trichopoulos, D. PalliF. Berrino, S. Panico, R. Tumino, C. Sacerdote, I.T. Gram, E. Lund, J.R. Quiros, N. Travier, C. Martinez-Garcia, N. Larranaga, M.D. Chirlaque, E. Ardanaz, G. Berglund, E. Lundin, H.B. Bueno de Mesquita, F.J.B van Duijnhoven, P.H.M. Peeters, S. Bingham, K.T. Khaw, N. Allen, T.J. Key, P. Ferrari, S. Rinaldi, N. Slimani, E. Riboli

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionMetabolic syndrome, plasma lipid, lipoprotein and glucose levels, and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC).
Original languageUndefined/Unknown
Pages (from-to)755-767
Number of pages13
JournalEndocrine-Related Cancer
Volume14
Issue number3
Publication statusPublished - 2007

Cite this